6509 | Humans |
3576 | Male |
3402 | Female |
3357 | Indium Radioisotopes (diagnostic use) |
2874 | Animals |
2287 | Middle Aged |
2127 | Adult |
1826 | Indium (diagnostic use) |
1689 | Aged |
1374 | Radioisotopes (diagnostic use) |
1170 | Mice |
1010 | Indium (chemistry) |
908 | Tissue Distribution |
792 | Antibodies, Monoclonal (diagnostic use) |
744 | Indium |
714 | Time Factors |
695 | Rats |
669 | Radiopharmaceuticals (diagnostic use) |
633 | Technetium (diagnostic use) |
633 | Pentetic Acid (diagnostic use) |
623 | Radionuclide Imaging |
617 | Leukocytes |
592 | Radioisotopes |
574 | Sensitivity and Specificity |
494 | Adolescent |
487 | Oxyquinoline (analogs & derivatives) |
481 | Indium Radioisotopes (pharmacokinetics) |
468 | Tin Compounds (chemistry) |
465 | Octreotide (diagnostic use) |
447 | Oxyquinoline (diagnostic use) |
430 | Surface Properties |
429 | Organometallic Compounds (diagnostic use) |
427 | Octreotide (analogs & derivatives) |
424 | Iodine Radioisotopes (diagnostic use) |
419 | Indium Radioisotopes |
408 | Tomography, Emission-Computed, Single-Photon |
407 | Pentetic Acid (analogs & derivatives) |
395 | Electrodes |
386 | Mice, Nude |
380 | Tomography, X-Ray Computed |
379 | Somatostatin (analogs & derivatives) |
360 | Dogs |
346 | Equipment Design |
342 | Aged, 80 and over |
331 | Isotope Labeling |
326 | Particle Size |
316 | Kinetics |
302 | Somatostatin (diagnostic use) |
289 | Child |
288 | Rabbits |
285 | Radiopharmaceuticals (pharmacokinetics) |
284 | Materials Testing |
283 | Blood Platelets |
279 | Methods |
276 | Radioimmunodetection |
270 | Gallium (chemistry) |
270 | Catalysis |
262 | Cell Line, Tumor |
260 | Molecular Structure |
255 | Neoplasm Transplantation |
250 | Mice, Inbred BALB C |
249 | Reproducibility of Results |
248 | Diagnosis, Differential |
247 | Blood Platelets (physiology) |
246 | Equipment Failure Analysis |
244 | Gallium Radioisotopes (diagnostic use) |
240 | Organometallic Compounds |
240 | Indium Radioisotopes (therapeutic use) |
237 | Receptors, Somatostatin (analysis) |
237 | Nanostructures (chemistry) |
226 | Antibodies, Monoclonal (pharmacokinetics) |
223 | Pregnancy |
223 | Microscopy, Electron, Scanning |
222 | Cell Survival |
220 | Isotope Labeling (methods) |
212 | Prospective Studies |
205 | Technetium |
204 | Semiconductors |
198 | Arsenicals (chemistry) |
196 | Liver (metabolism) |
195 | Magnetic Resonance Imaging |
189 | Temperature |
188 | Indium (metabolism) |
187 | Oxidation-Reduction |
186 | Hydroxyquinolines (diagnostic use) |
186 | Antibodies, Monoclonal (therapeutic use) |
185 | Transplantation, Heterologous |
183 | Electrochemistry |
181 | Neoplasms (radionuclide imaging) |
181 | Follow-Up Studies |
179 | Quantum Dots |
172 | Radiation Dosage |
172 | Pentetic Acid (pharmacokinetics) |
171 | Nanotechnology (methods) |
170 | Heart (radionuclide imaging) |
169 | Evaluation Studies as Topic |
166 | Retrospective Studies |
166 | Myosins (immunology) |
163 | Light |
162 | Receptors, Somatostatin (metabolism) |
161 | Cells, Cultured |
160 | Child, Preschool |
159 | Hydrogen-Ion Concentration |
159 | Carcinoid Tumor (radionuclide imaging) |
157 | Tumor Cells, Cultured |
156 | Blood Vessel Prosthesis |
155 | Indium Radioisotopes (chemistry) |
154 | Molecular Conformation |
153 | Octreotide (therapeutic use) |
152 | Carcinoembryonic Antigen (immunology) |
151 | Osteomyelitis (radionuclide imaging) |
151 | Liver (radionuclide imaging) |
149 | Crystallization (methods) |
147 | Predictive Value of Tests |
147 | Nanostructures (ultrastructure) |
146 | Lung (radionuclide imaging) |
146 | Abscess (radionuclide imaging) |
144 | Treatment Outcome |
144 | Organotechnetium Compounds (diagnostic use) |
144 | Neoplasm Metastasis |
141 | Liver Neoplasms (secondary) |
138 | Nanoparticles (chemistry) |
138 | Myocardial Infarction (radionuclide imaging) |
138 | Injections, Intravenous |
138 | Antibodies, Monoclonal (immunology) |
137 | Half-Life |
136 | Organometallic Compounds (chemistry) |
135 | Radionuclide Imaging (methods) |
135 | Pancreatic Neoplasms (radionuclide imaging) |
135 | Lung Neoplasms (radionuclide imaging) |
134 | Stereoisomerism |
134 | Radiopharmaceuticals (therapeutic use) |
132 | Polymers (chemistry) |
131 | Neuroendocrine Tumors (radionuclide imaging) |
131 | Gold (chemistry) |
130 | Tomography, Emission-Computed, Single-Photon (methods) |
130 | Liver Neoplasms (radionuclide imaging) |
129 | False Positive Reactions |
128 | Radioimmunotherapy |
126 | Tomography, Emission-Computed |
126 | Metabolic Clearance Rate |
125 | Electric Conductivity |
124 | Infant |
123 | Disease Models, Animal |
121 | Yttrium Radioisotopes (therapeutic use) |
119 | Neoplasm Recurrence, Local (radionuclide imaging) |
119 | Models, Molecular |
119 | Electrochemistry (methods) |
119 | Biosensing Techniques (methods) |
118 | Octreotide (pharmacokinetics) |
116 | Swine |
116 | Metal Nanoparticles (chemistry) |
114 | Rats, Inbred Strains |
114 | Models, Chemical |
113 | Rats, Wistar |
111 | Phosphines (chemistry) |
111 | Indium Radioisotopes (administration & dosage) |
111 | Electrons |
109 | Platelet Count |
108 | Computer Simulation |
108 | Cell Line |
107 | Protein Binding |
107 | Neoplasm Staging |
107 | Bone Marrow (radionuclide imaging) |
106 | Blood Platelets (radionuclide imaging) |
105 | Polytetrafluoroethylene |
105 | Kidney (metabolism) |
105 | Antibodies, Monoclonal (metabolism) |
104 | Prostatic Neoplasms (radionuclide imaging) |
103 | X-Ray Diffraction |
103 | Thrombosis (radionuclide imaging) |
103 | Copper (chemistry) |
103 | Acute Disease |
102 | Technetium Tc 99m Medronate (diagnostic use) |
102 | Indium (analysis) |
102 | Autoradiography |
101 | Prognosis |
100 | Inflammation (radionuclide imaging) |
99 | Thyroid Neoplasms (radionuclide imaging) |
99 | Colorectal Neoplasms (radionuclide imaging) |
99 | Chronic Disease |
99 | Cell Movement |
98 | Blood Platelets (drug effects) |
97 | Spleen (radionuclide imaging) |
97 | Leukocytes (radionuclide imaging) |
97 | Immunohistochemistry |
97 | Adenocarcinoma (radionuclide imaging) |
96 | Ligands |
96 | Indium Radioisotopes (metabolism) |
96 | Drug Stability |
96 | Biosensing Techniques (instrumentation) |
95 | Macromolecular Substances (chemistry) |
95 | Lung (metabolism) |
95 | Breast Neoplasms (radionuclide imaging) |
94 | Indium (toxicity) |
94 | Colloids |
93 | Solar Energy |
92 | Nanotechnology (instrumentation) |
92 | Infection (radionuclide imaging) |
92 | Blood Platelets (metabolism) |
92 | Antibodies, Monoclonal |
91 | Heterocyclic Compounds, 1-Ring (chemistry) |
91 | Colonic Neoplasms (radionuclide imaging) |
89 | Technetium Tc 99m Sulfur Colloid (diagnostic use) |
89 | Spleen (metabolism) |
89 | Graft Rejection |
88 | Radioimmunodetection (methods) |
88 | Melanoma (radionuclide imaging) |
87 | Pentetic Acid (chemistry) |
87 | Nanotubes (chemistry) |
87 | Antibodies, Monoclonal (administration & dosage) |
86 | Radioimmunotherapy (methods) |
86 | Platelet Aggregation |
86 | Immunoglobulin G (diagnostic use) |
85 | Tropolone (diagnostic use) |
85 | Rats, Sprague-Dawley |
85 | Radiopharmaceuticals (chemistry) |
85 | Pentetic Acid |
85 | Granulocytes |
84 | Organometallic Compounds (pharmacokinetics) |
84 | Microscopy, Atomic Force |
84 | Dose-Response Relationship, Drug |
83 | Myocardium (pathology) |
83 | Membranes, Artificial |
83 | Erythrocytes |
83 | Chromatography, High Pressure Liquid |
83 | Chelating Agents (chemistry) |
82 | Technetium Tc 99m Exametazime |
82 | Ovarian Neoplasms (radionuclide imaging) |
82 | Indium (administration & dosage) |
82 | Adsorption |
81 | Oxides (chemistry) |
81 | Biopsy |
81 | Amino Acid Sequence |
80 | Positron-Emission Tomography |
80 | Pentetic Acid (metabolism) |
80 | Bleomycin (diagnostic use) |
79 | Radiotherapy Dosage |
79 | Models, Biological |
79 | Mice, Inbred C57BL |
78 | Platelet Aggregation (drug effects) |
78 | Oximes (diagnostic use) |
78 | Gastric Emptying |
78 | False Negative Reactions |
77 | Tin Compounds |
77 | Regional Blood Flow |
77 | Liver Neoplasms (diagnosis) |
77 | Kidney (radionuclide imaging) |
77 | Crohn Disease (radionuclide imaging) |
76 | Electrochemistry (instrumentation) |
75 | Brain Neoplasms (diagnosis) |
75 | Antigens, Neoplasm (immunology) |
74 | Molecular Sequence Data |
74 | Lymphatic Metastasis |
74 | Iodine Radioisotopes |
73 | Hot Temperature |
72 | Nanowires (chemistry) |
72 | Microspheres |
72 | Cell Adhesion |
71 | Recurrence |
71 | Colon (radionuclide imaging) |
71 | Cell Survival (drug effects) |
70 | Water (chemistry) |
70 | Gamma Cameras |
70 | Chromium Radioisotopes (diagnostic use) |
70 | Bone Neoplasms (radionuclide imaging) |
69 | Radiometry |
69 | Indium (blood) |
69 | Crystallography, X-Ray |
69 | Bone and Bones (radionuclide imaging) |
68 | Thrombophlebitis (radionuclide imaging) |
68 | Silicon (chemistry) |
68 | Radioisotopes (metabolism) |
67 | Zinc Oxide (chemistry) |
67 | Magnetic Resonance Spectroscopy |
67 | Electrochemical Techniques |
66 | Antibodies, Monoclonal (chemistry) |
65 | Tropolone (analogs & derivatives) |
65 | Thrombosis (etiology) |
65 | Silver (chemistry) |
65 | Microelectrodes |
65 | Combined Modality Therapy |
65 | Cattle |
65 | Breast Neoplasms (metabolism) |
64 | Placenta (blood supply) |
64 | Microscopy, Electron, Transmission |
63 | Radiopharmaceuticals (administration & dosage) |
63 | Radioisotope Dilution Technique |
63 | Postoperative Complications (radionuclide imaging) |
63 | Organ Specificity |
63 | Neoplasms (metabolism) |
63 | Lymph Nodes (radionuclide imaging) |
63 | Liver Diseases (diagnosis) |
63 | Indicators and Reagents |
63 | Crystallization |
62 | Ultrasonography |
62 | Sulfides (chemistry) |
61 | Solutions |
61 | Radiopharmaceuticals (chemical synthesis) |
61 | Polyethylene Terephthalates |
61 | Placenta |
61 | Oligopeptides (diagnostic use) |
61 | Neoplasms (diagnosis) |
61 | Iodine Radioisotopes (therapeutic use) |
61 | Image Processing, Computer-Assisted |
60 | Titanium (chemistry) |
60 | Reference Values |
60 | Rats, Inbred Lew |
60 | Papio |
60 | Neutrophils (physiology) |
60 | Leukocyte Count |
60 | Citrates (diagnostic use) |
60 | Bone Neoplasms (secondary) |
59 | Transferrin (diagnostic use) |
59 | Scattering, Radiation |
59 | Peptides (chemistry) |
59 | Organometallic Compounds (chemical synthesis) |
59 | Lasers |
59 | Indium (pharmacology) |
59 | Dose-Response Relationship, Radiation |
59 | Bacterial Infections (radionuclide imaging) |
58 | Neoplasms (radiotherapy) |
58 | Microscopy, Electron |
58 | Luminescence |
57 | Yttrium Radioisotopes (pharmacokinetics) |
57 | Thallium Radioisotopes (diagnostic use) |
57 | Stomach (radionuclide imaging) |
57 | Prostatic Neoplasms (pathology) |
57 | Nanotubes (ultrastructure) |
57 | Cyclization |
57 | Algorithms |
56 | Neoplasms, Experimental (metabolism) |
56 | Kidney Transplantation |
56 | Iodine Radioisotopes (pharmacokinetics) |
56 | Clinical Trials as Topic |
55 | Pulmonary Circulation |
55 | Indium (radiation effects) |
55 | Immunoglobulin Fab Fragments (diagnostic use) |
55 | Antineoplastic Agents (therapeutic use) |
54 | Transferrin (metabolism) |
54 | Spectrophotometry, Ultraviolet |
54 | Neoplasms, Experimental (radionuclide imaging) |
54 | Gastrointestinal Neoplasms (radionuclide imaging) |
54 | Electric Power Supplies |
54 | Brain Neoplasms (radionuclide imaging) |
52 | Somatostatin (therapeutic use) |
52 | Solubility |
52 | Lung (pathology) |
52 | Isotopes |
52 | Heart Transplantation |
52 | Gallium |
52 | Feasibility Studies |
52 | Cricetinae |
52 | Breast Neoplasms (pathology) |
52 | Blood Platelets (cytology) |
51 | Serum Albumin (diagnostic use) |
51 | Photochemistry (methods) |
51 | Necrosis |
51 | Inflammatory Bowel Diseases (radionuclide imaging) |
51 | Guinea Pigs |
51 | Electron Transport |
51 | Antibodies, Monoclonal, Humanized |
51 | Abdomen (radionuclide imaging) |
50 | Zinc (chemistry) |
50 | Radioisotopes (therapeutic use) |
50 | Placenta Previa (diagnosis) |
50 | Photons |
50 | Optics and Photonics |
50 | Lighting (instrumentation) |
50 | Immunoconjugates (pharmacokinetics) |
49 | Quantum Theory |
49 | Palladium (chemistry) |
49 | Infant, Newborn |
49 | Glass (chemistry) |
49 | Citric Acid |
49 | Binding, Competitive |
48 | Xenograft Model Antitumor Assays |
48 | Transistors, Electronic |
48 | Somatostatin (pharmacokinetics) |
48 | Serum Albumin, Radio-Iodinated (diagnostic use) |
48 | Positron-Emission Tomography (methods) |
48 | Nanotubes, Carbon (chemistry) |
48 | Immunoglobulin Fab Fragments (immunology) |
48 | Blood Vessel Prosthesis (adverse effects) |
48 | Analysis of Variance |
47 | Whole-Body Counting |
47 | Tin |
47 | Thrombosis (prevention & control) |
47 | Polystyrenes (chemistry) |
47 | Mice, SCID |
47 | Gastric Emptying (physiology) |
47 | Fluorodeoxyglucose F18 (diagnostic use) |
47 | Drug Carriers |
47 | Colitis, Ulcerative (radionuclide imaging) |
47 | Carcinoma, Medullary (radionuclide imaging) |
47 | Cadmium Compounds (chemistry) |
46 | Transplantation, Homologous |
46 | Sheep |
46 | Models, Theoretical |
46 | Aldehydes (chemistry) |
45 | Tomography, X-Ray Computed (methods) |
45 | Tomography, Emission-Computed (methods) |
45 | Technetium Tc 99m Aggregated Albumin (diagnostic use) |
45 | Splenectomy |
45 | Spectroscopy, Fourier Transform Infrared |
45 | Pilot Projects |
45 | Myocarditis (radionuclide imaging) |
45 | Metals (chemistry) |
45 | Lymphatic Metastasis (radionuclide imaging) |
45 | Immunoglobulin G (metabolism) |
45 | Gastrointestinal Transit |
45 | Echocardiography |
45 | Drug Delivery Systems |
45 | Colonic Neoplasms (metabolism) |
45 | Chelating Agents (pharmacokinetics) |
45 | Carcinoid Tumor (secondary) |
45 | Biological Transport |
44 | Yttrium Radioisotopes (diagnostic use) |
44 | Phantoms, Imaging |
44 | Mice, Inbred Strains |
44 | Indium Radioisotopes (blood) |
44 | Gamma Rays |
44 | Femoral Artery (surgery) |
44 | Electrocardiography |
44 | Electric Impedance |
44 | Carcinoma (radionuclide imaging) |
44 | Biosensing Techniques |
44 | Antineoplastic Agents, Hormonal (therapeutic use) |
44 | Antibody Specificity |
43 | Uterus (blood supply) |
43 | Rectal Neoplasms (radionuclide imaging) |
43 | Pentetic Acid (therapeutic use) |
43 | Pentetic Acid (administration & dosage) |
43 | Pancreatic Neoplasms (pathology) |
43 | Pancreatic Neoplasms (metabolism) |
43 | Pancreatic Neoplasms (diagnosis) |
43 | Neuroendocrine Tumors (radiotherapy) |
43 | Lymphoma (radionuclide imaging) |
43 | Lymphocytes (immunology) |
43 | Graphite (chemistry) |
43 | Coronary Circulation |
43 | Chelating Agents |
43 | Bone Marrow (metabolism) |
43 | Binding Sites |
43 | Antibodies, Monoclonal (adverse effects) |
42 | Zinc Compounds (chemistry) |
42 | Serum Albumin, Radio-Iodinated |
42 | Receptor, erbB-2 (metabolism) |
42 | Radiopharmaceuticals (metabolism) |
42 | Pulmonary Embolism (radionuclide imaging) |
42 | Perfusion |
42 | Neutrophils |
42 | Myocardium (metabolism) |
42 | Lung Diseases (diagnosis) |
42 | Immunoglobulin Fab Fragments |
42 | Contrast Media |
42 | Cell Separation |
42 | Angiography |
42 | Administration, Oral |
42 | Abscess (diagnosis) |
42 | Abdomen |
41 | Tin (chemistry) |
41 | Physicochemical Phenomena |
41 | Infusions, Intravenous |
41 | Computer-Aided Design |
41 | Carbon (chemistry) |
41 | Aluminum (chemistry) |
40 | Platelet Adhesiveness |
40 | Pituitary Neoplasms (radionuclide imaging) |
40 | Phagocytosis |
40 | Lung (blood supply) |
40 | Liver |
40 | Food |
40 | Electrochemical Techniques (methods) |
40 | Edetic Acid (diagnostic use) |
40 | Diagnostic Errors |
40 | Chelating Agents (diagnostic use) |
40 | Carcinoma, Small Cell (radionuclide imaging) |
40 | Aerosols |
39 | Thiophenes (chemistry) |
39 | Structure-Activity Relationship |
39 | Staining and Labeling |
39 | Spectrum Analysis |
39 | Silicon Dioxide (chemistry) |
39 | Refractometry (instrumentation) |
39 | Photochemistry |
39 | Octreotide (metabolism) |
39 | Mathematics |
39 | Lung (drug effects) |
39 | Indium (pharmacokinetics) |
39 | Hemodynamics |
39 | Enzymes, Immobilized (chemistry) |
39 | Endothelium, Vascular (cytology) |
39 | Chemistry, Physical |
39 | Cardiac Output |
39 | Carcinoembryonic Antigen (analysis) |
39 | Brain Diseases (diagnosis) |
39 | Antibodies, Monoclonal (pharmacology) |
39 | Adenocarcinoma (secondary) |
38 | Young Adult |